Target intelligence / Profile preview

Neuroinflammation

Molecular classification
Other
01

Overview

Neuroinflammation is a complex biological process characterized by the activation of the innate immune system within the central nervous system (CNS) in response to harmful stimuli, such as pathogens, metabolic toxic aggregates, or injury. It is primarily mediated by the activation of microglia and astrocytes, which release a variety of pro-inflammatory mediators including cytokines, chemokines, and reactive oxygen species (StatPearls, 2023). While acute neuroinflammation serves as a defense mechanism to protect the brain, chronic or dysregulated neuroinflammation is a key driver of neurodegeneration and is central to the pathology of diseases like Alzheimer's and Multiple Sclerosis (Nature Reviews Immunology, 2020). Because it is a multi-faceted physiological state involving numerous signaling pathways and cell types, it is considered a pathological process or therapeutic area rather than a single discrete molecular target. Therapeutic interventions usually focus on specific molecular components within this process, such as the NLRP3 inflammasome or specific cytokine receptors, to restore CNS homeostasis (Frontiers in Pharmacology, 2021).

Other names
Brain inflammationCentral nervous system inflammationCNS inflammationNeural inflammation
02

Mechanism of action

Modulation of glial activation, inhibition of pro-inflammatory cytokines, and stabilization of the blood-brain barrier.

03

Biological functions

Immune responseCytokine productionGlial activationTissue repairHomeostasis
04

Disease associations

Alzheimer's diseaseParkinson's diseaseMultiple SclerosisAmyotrophic lateral sclerosisStrokeTraumatic brain injury
05

Safety considerations

ImmunosuppressionIncreased risk of opportunistic infectionsPotential interference with beneficial neuroprotective inflammatory responses
06

Interacting drugs

Dimethyl fumarate

4 more in the full profile.

07

Biomarkers

Translocator protein (TSPO) PET imagingGlial fibrillary acidic protein (GFAP)Neurofilament light chain (NfL)Interleukin-6 (IL-6)Tumor necrosis factor alpha (TNF-α)

Beyond the preview

Go deeper on Neuroinflammation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroinflammation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call